IL-6 secreted from senescent mesenchymal stem cells promotes proliferation and migration of breast cancer cells.
Human mesenchymal stem cells (hMSCs) are currently investigated for a variety of therapeutic applications. However, MSCs isolated from primary tissue cannot meet clinical grade needs and should be expanded in vitro for several passages. Although hMSCs show low possibility for undergoing oncogenic tr...
Main Authors: | Guo-Hu Di, Yang Liu, Ying Lu, Jin Liu, Chutse Wu, Hai-Feng Duan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4242635?pdf=render |
Similar Items
-
Human umbilical cord mesenchymal stromal cells promotes the proliferation and osteogenic differentiation of autologous bone marrow stem cells by secreting exosomes
by: Hai, Y., et al.
Published: (2022) -
Downregulation of FOXO6 in breast cancer promotes epithelial–mesenchymal transition and facilitates migration and proliferation of cancer cells
by: Ye H, et al.
Published: (2018-10-01) -
Stem Cell-Derived Exosomes and Nanovesicles: Promotion of Cell Proliferation, Migration, and Anti-Senescence for Treatment of Wound Damage and Skin Ageing
by: Hyeonjin Cha, et al.
Published: (2020-11-01) -
Role of Hyperglycemia in the Senescence of Mesenchymal Stem Cells
by: Min Yin, et al.
Published: (2021-04-01) -
MiR-495 Promotes Senescence of Mesenchymal Stem Cells by Targeting Bmi-1
by: Xiujun Li, et al.
Published: (2017-06-01)